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D94929 PredictiveValueof ExercieeTestingfortheDetectionof Isolatedor Non-isolatedLeftMain
CoronaryArteryStenosis
C.C. de Cock, J. Paats, J.G.F. Bronzwaer, CA. Visser. Free University
Hospital, Amsterdam, The Netherlands
To evaluate exercise test results and coronaq! anatomy in patients referred
for the evaluation of chest pain, we reviewed the coronary angiograms and
exercise tests (Bruce protocol) of 2813 consecutive patients. All patients un-
derwent symptom limited exercise testing two days prior to cardiac catheteri-
zation. Left main coronary stenosis (LMCS) was present in 121patients (pts):
34 had isolated LMCS (group 1), while 87 had concomitant coronaw artery
disease (group 2). Matched control pts with 3-vessel disease (group 3) had
significantly iesa exertional hypotension i.e. <20 mmHg increase in systolic
biood pressure (12Yo)compared to group 1 (22%) and group 2 (24%, p <
0.01), ionger exercise duration (8.5+ 1.4 rein) compared to group 1 (4.4+
1.2 rein, p < 0.001) and group 2 (4.1 & 1.1 rein, p < 0.001) and less exercise
induced atrial arrhythmias (3.1%) compared to group 1 (8.OYO,p c 0.001).
In addition, termination of the test because of signs of cerebral hypoper-
fusion (pre-syneope or dizzyness) was present in 3% in group 1 and 5% in
group 3, p = ns, compared to 18% in group 2 (p < 0.001). From eisctrocar-
diographic abnormalities, only one (ST-segment depression ?1 mm in 57
leads including ST-segment elevation in V2) was different in pts with LMCS
(18% in group 1, 22% in group 2) compared to pts in group 3, (l%, p c
0.001). Multivariate analysia revealad that signs of cerebral hypoperfusion,
exertional hypotension and atrial arrhythmias were the 3 independent pre-
dictor of LCMS; clinical signs of cerebral hypoperfusion is suggestive for
LMCS in addition to conmmitant coronary arte~ disease.
PI CostEffectivenessAnalYsisofStressMYo~ardial
PerfusionImaginginStableAnginaPatients:
InfluenceofAgeandPreteetRiskof Coronary
Disease
L.J. Shaw, R. Hachamovitch, T.H. Marwick, G.V. Heller, D.S. Berman,
S. Borges-Neto, Ml. Travin, M.S. Lauer, D.D. Miller, for the Economics of
Noninvasive Diagnosis Multicenter Study Group. Duke University Durham,
NC
Cost effaetiveness analysis (CEA) evaluates the outcomes and costs of in-
terventions designed to improve health. Cost effectiveness data for stress
myoeardial imaging in 9,791 stable angina patients (35% female, 42% rs-
veraible defects) enrolled from 7 hospitals (annual cardiac death rate =0.9%
over 2.5 & 1.5 years) was obtained from each hospital using a top-down
coeting approach, adjusting Medicare charges by coat-charge ratios + Msdi-
care fee schedule for physician costs. CEA = ACost/Alife expectancy from
United States population-based tables (cost discount rate = 5%). The table
below indicates CEA for clinically low (S 15%), intermediate (18-60%), and
high (> 60%) risk patients (reference case age= 80 years).
PretestCsrdiacRisk(n) AnnualCardiacDeath CEA
All Elderly
Low(S26) 0.6”A $254s209 $34,650
intermediate(3,3SS) 1.6”/0 $2S,SS7 $23,310
High (1,607) 4,4”h $52,960 $42,737
In classifying CEA by age deciles, a standardized CEA threshold of
<$50,000 was achieved for low and high risk patients aged 2-70years.
Conclusion.’Use of stress myocardial perfusion imaging is most cost ef-
fective in intermediate risk patients who present with stable angina symptoms
or for those who are elderly.
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m950155 Clinical,EchocardiographicandExercisePredictorsof Outcomeina ProspectiveStudyof
ValvularAotticStenosis
C.M. Otto, LG. Burwash, M.E. Legget, B.1.Munt, N.L. Healy. Urriversifyof
Washington, Seattle, WA, USA
In 123 adults (mean age 83 + 18 years) with asymptomatic aortic stenosis
(AS), annual clinical, echocardiographic and exercise data were obtained
prospectively over a mean follow-up of 2.5 + 1.4 (range 0.3 to 8.3) yrs.
AS-jet velocity (Vma) changed by 0.32+ 0.34 m/s/yr, mean gradient (AP) by
7 l7 mmH@yrand valve area (AVA)by -0.12 + 0.19 cm2/yr. Kaplan Meier
event-free survival, with endpointe defined as death (n = 8) or aortic valve
replacement (AVR) (n = 48), was 93 +5% at 1 year, 62 +6% at 3 yeare and
26+ 10% at 5 years.
Univariate predictors of AVR or daath included baseline V~U (3.9 + 0.5
vs 3.3 + 0.5 mfs, p < 0.001), mean AP (38 + 12 vs 25 + 8 mmHg, p <
0.001), AVA (1.11 + 0.34 vs 1.53 + 0.53 cmz, p < 0.001), and the rate of
increase in V~m (0.45+ 0.42 vs 0.23 + 0.22 rn/a/yr p = 0.001), but not age,
gender or etiology of AS. Those with an endpoint had a smaller exercise
increase in AVA(0.05 & 0.28 vs 0.27 + 0.38 cm2, p = 0.001), blood pressure
(15 + 7 vs 29 + 20 mmHg) and cardiac output (5.9 +4.2 vs 8.5 + 4.7, p =
0.004), and a greater exercise decrease in stroke volume (-12 + 20 vs –2
+23 ml, p = 0.03).
On Cox regression analysis, multivariate predictors of clinical outcome
were V-at baseline (p < 0.0001), the rate of change in VmaX(p < 0.0001)
and functional status score (p = 0.002), For those with VmaX>4.0 m/s, the
likelihood of remaining alive without AVR at 2 years was only 21 + 18%,
compared to 66 + 13% for a V~~ of 3.0-4.0 rris and 64 & 160/.for a Vma,
<3.0 m/s (p<0.0001).
These data will be helpful in management and foliow-up of adults with
asymptomatic AS and will be useful in designing future trials of interventions
to slow disease progression.
1950-1561FIO~-Dependen~eOfAotticStenosisSeverity:
Comparisonofthe GorlinsndContinuity
EquationswithDirectPlanimetryofthe
AnatomicalOrificeduringTraneesophageal
Echocardiography
J.-L. Vanoverschelde, A. Pasquet, A.-M. D’Hondt, M. De Kock. University of
Louvain, Brussels, Belgium
Increase in aortic valve area (AVA) with increasing flow rates is common
when using the Gorlin and the continuity equations for AVA calculation.
To test whether these changes reflect true increases in anatomical area
or inaccuracies in calculation methods, right heart hemodynamics (7 Fr
Swan Ganz), cardiac output (thermodilution), transaortic flow velocity (CW
Doppler) and direct planimetry of the anatomical orifice (TEE) were obtained
simultaneously in’7 patients with isolated aortic stenosis (AVA: 0.63 + 0.14
cm2),at baseline and during infusion of 10 @/kg/rein of dobutamine. Infusion
of dobutamine resulted in significant increases in heart rate (from 81 + 12 to
91 +22 bpm), cardiac output (from 3.4+ 1.9 to 5.3 & 2.7 Umin), transaortic
flow rates (159 * 36t0249 + 45 mUs) and mean pressure gradient (from 33
+ 17 to 50 + 28 mmHg). As axpected, AVAScalculated with both the Goriin
(+29%, from 0.65 + 0.14 to 0.84 + 0.16 cmz, p < 0.02) and the continuity
(+30%, from O.&l + 0.13 to 0.76 + 0.17 cm2, p < 0.03) equations increased
with increasing flow rates. No significant changes were noted, however, in
AVA measured by planimetry (from 0.63+ 0.22 to 0.81 + 0.23 cmz, p = ns).
At low flow rates, TEE AVA correlated weakly with that calculated with the
Gorlin (r= 0.56) or the continuity (r= 0.56) equations. Correlations improved
at high flow rates (r = 0.77 and 0.79, respectively). Thus, the data indicate
that AVAScalculated with the Gorlin and the continuity equations increase
with flow rates, while true anatomical orifice area does not. As calculated
AVASunderestimate the true anatomical area at low flow rates, their flow-
dependence probably reflects flow-dependent changes in the coefficient of
orifice contraction.
I-I ChangeslnCoronaryBloodFlowkt”RelstionTo
ChangesInHemodynamicParametersDuring
BetsBlockadeIn PatientsWithAorticValve
Stenosis
M. Kyriakidis, J. Dernellis, A. Trikas, J. Barbetseas, C. Tentolouris,
A.,Anastasakis, J. Giaiafos, P.Toutouzas. Department of Cardiology,
f-fippokrationf-fospifa/,University of Athens, Greece
AIterations in coronary flow velocity (CFV) have been demonstrated at rest
in patients with aortic valve stenoais (AVS) but have never been etudiad
after beta-adrenoreceptor blocker administration. Twenty-three patients with
significant pure AVS (14 with exertional symptoms [group 1], 9 asymptomatic
[group 2] and 8 control subjects [group 3], all with normal coronary arteries,
were studied successively at rest, after esmolol infusion (bolus dose of 500
&/kg/min and by continuous infusion of 50 @kg/rein) and after atropine
administration (0.025 to 0.040 mg/kg) by proximal left anterior descending
(IAD) intracoronary Doppierflowvelocimetry concomitant with hemodynamic
measurements. In all patients, cardiac index increased after atropine but
it decfeaaed after esmolol. Svstolic retrograde CFV was recorded onlv in
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patients with AVS. In group 1, there was lower aortic valve area (0.59 vs
0.77 cmz) and higher peak systolic retrograde CFV than in group 2, and also
higher resting peak diastolic CFV than in groupa 2 and 3. In the two AVS
gmupe, retrograde CFV decreased significantly after esmolol (group 1 from
-13.8 to –6.5, gmup2from -6.6 to -3.5 cr’r’tlsec,p < 0.01) while it remained
unchanged after atropine. Diastolic CFV was significantly higher in group 1
than in groups 2 and 3 (67.2 vs 30.7 and 19.4 crnfsec, respectively, p <
0.01) and significantly decreased after atropine in all subjects. Afferesmolol,
it increased in patients with AVS (group 1 to 85.1, group 2 to 58.4 cmkec, p
<0. 001) but did not change in group 3. Conclusions: Beta-adrenoreceptor
blockers administered acutely to patients with symptomatic or asymptomatic
AVS resulted in beneficial coronary flow effects. These changes are closely
related to the concomitant beta-blockade induced changes in hemodynamic
parameters.
1950-1581 CanPatientsWithSevereAotiicSteno9is
UndergoNoncardiacSurgeryWithAcceptable
Risk?
L.C. Toreher,C. Shub, S.R. Rettke, D.L. Brown. Mayo Clinic, Rochesteq
MN, USA
Aortic stenosis (AS) is a major risk factor for perioperative cardiac eventa in
patients (pts) undergoing noncardiac surgery (NCS). We previously showed
that a small group.of selected pts with AS, who were not candidates for,
or refused, aoftic valve replacement (AVR), were able to undergo NCS with
increased, butacceptable, risk. We extended our previous experience over
a subsequent five year period by retrospectively analyzing the perioperative
muree of all eases with severe AS (AVarea index <0.5 cm2/m2or gradient >
50 mmHg) by Doppler echooardiography undergoing NCS. 3 pts underwent
preop aottic balloon valvuloplasfy, but post procedure still had severe AS.
Results: 20 pta, mean age 73 + 7 yeare, undetwent 29 operative pro-
cedure (23 elective and 6 emergency): 13 orthopedic, 5 vascular, 5 intra-
abdominal, 4 urologic, 1 ENT,and 1 thoracic. 17 pts (65%) had one or more
symptoms: dyspnea (15), angina (5), syncope orpresyncope (5). Mean LVEF
was 81 + 13.27 @zsesunderwent general anesthesia and 2 spinal anes-
thesia. Intra-arterial monitoring of blood pressure was used in 20 of the 29
cases.
Intraoperative hypotensive events were treated promptly, primarily with
phenylephrine. 2 elderly pts had a complicated course and died. The first,
a 90-year-old male presenting with hypotension and progressive metabolic
acidosis underwent emergency mesenteric artery embolectomy, developed
multiorgan failure and support was electively withdrawn 19 days postop.
The second, an 89-year-old female underwent elective bilateral total knee
arthroplasty, suffered an Ml on the second postop day, developed multiorgan
failure, and died 17 days postop. There were no other intra or perioperative
cardiac events.
Conclusions: Selected patients with severe AS, who are otherwise not
oendidatea for AVR, with appropriate intra and perioperative management,
including prompt recognition and treatment of intraoperative hypotension,
can undergo NCS with acceptable risk.
m950159 IsTherea FluidMechanicalExplanationforCriticalOrificeAreasin Aortic”Valve Stenosis? An
inVitroStudy
R.S. Heinrich, R.A. Marcus, A.E. Ensley, S.R. Hashim, DE. Gibson,
A.P. Yoganathan. Iowa Heari CenteL Des Moines, 1A,USA, Chicago, IL,
USA, Gaorgia Tech,Atlanta, GA, USA
The reason for the apparent clinical predisposition to hemodynamic decom-
pensation at a specific valve area (<0.75 cm2) among patients with aortic
stenosis is not clear. The purpose of this study was to detarmine if there was
a fluid mechanical explanation for the observed clinical complications that
occur at the critical orifice area among patients with aortic valve stenosis.
In vitro experiments were performed to enable precise measurement of me-
chanical work in models of aortic stenosis. Nozzles with orific? areas ranging
from 1.27-0.5 cmz were examined in a mock circulatory system. Pulsatile
flow (flow rate = 2-7 Umin.) was pumped through the nozzles at a heart
rate of 60 bpm. Pump work was calculated by measuring flow rate, pressure
and on a contmi volume surrounding the model and applying eonsewation of
energy. For all stroke volumes, there was a strfking increase in mechanical
work ae orifice areas decreased from 1.0 to 0.75 cm2, as shown in the figure.
Mechanical work increased 10.9% as stenotic orifice area deereased from
1.27 to 1.0 cm2 but increased 87.9% as the area decreased from 1.0 to 0.75
cm2.
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Conclusions; (i) As the valve area approaches the critical value in aortic
stenosis, the mechanical workload of the left vantricle is dramatically in-
creased. (ii) These findings could explain the consistent association betwa6n
critical aortic stenosis and hemodynamic decompensation. (iii) Serial non-
invasive analyaes of fluid mechanics might enable individualization of the
critical value in patients with aortic stenosis.
m950160 PumpWorkinSmallSizeAorticValveMechanicalProstheses:WhstAretheHemodvnamic
Consequencesof Choosinga Sm&llerValve?
R.S. Heinrich, R.A. Marcus, S.R. Hashim, A,E. Ensley, D.E. Gibson,
A.P. Yoganathan, Iowa Head Cente~ Des Moines, 1A,USA, Chicago, IL,
USA, Georgia Tech,Atlanta, GA, USA
The hemodynamic consequences of up- or down-sizing prostheses in pa-
tients undergoing aottic valve replacement need to be better elucidated. The
purpose of this atudy waa to determine the differences in workload and en-
ergy loss caused by small changes in prosthetic heart valve size. In vitro
experiments were performed to allow precise control and measurement of
mechanical work across small-size prosthetic aortic valves. Pulsatile flow
(flow rate = 2-7 Umin.) was pumped through 19, 21 and 23 mm St. Jude
bileaflet (SJM), and 21 and 23 mm Medtronic-Hall tilting disc (MH) vahrea.
Pump work was calculated by meaeuring pressure, flow rate and velocity
at the boundaries of a control volume surrounding the model and applying
consewation of energy.The SJM 19 mm valve required the largest work at all
stroke volumes (p < 0.05). Differences in work between valves of the same
size, but different type, were not significant. As valve diameter deereased
frOfT723to 21 mm, pump work increased by 9.1% (energy 10ssby 68.1%) for
both SJMand MH valves (p< 0.05). In the SJM valve, asdiameter decreased
from 21 to 19 mm, work increased by 13.7% (energy loss by 72.7%) (p <
0.05).
l.z~
, d l
..”
/
n
~0.8 A
S 0.6
+!
0 0.4
3
[
l
0.2 a
A
---
KIM
0.04
m
A
-n
I
i
mm
mm
mm
0.3
1. 19mml
o,o-
Cone/usion: Up- or down-sizing aorfic prostheses impacts significentfy
both on myocardial energy expenditure and on left ventricular mechanical
efficiency,The long term consequences of these effects on cardiac structure
and function merit further investigation.
